{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:42:29Z","timestamp":1792665749859,"version":"4.5.0"},"reference-count":20,"publisher":"MyJove Corporation","issue":"140","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/58492","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T20:00:20Z","timestamp":1539720020000},"source":"Crossref","is-referenced-by-count":9,"title":["A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells"],"prefix":"10.3791","author":[{"given":"Gray","family":"Kueberuwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Kalaitsidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Gilham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Hawkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"ref1","volume-title":"Food and Drugs Administration Biologics Licence Application Approval letter","author":"Brian","year":"2017","unstructured":"Brian, W. Food and Drugs Administration Biologics Licence Application Approval letter. <https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/CellularGeneTherapyProducts\/ApprovedProducts\/UCM574106.pdf>. (2017)."},{"key":"ref2","volume-title":"Food and Drugs Administration Biologics Licence Application Approval letter","author":"Malarkey","year":"2017","unstructured":"Malarkey, M., Brian, W. Food and Drugs Administration Biologics Licence Application Approval letter. <https:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/cellulargenetherapyproducts\/approvedproducts\/ucm581259.pdf>. (2017)."},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/CJI.0b013e3182518e83","type":"journal-article","article-title":"Cancer and Innate Immune System Interactions: Translational Potentials for Cancer Immunotherapy","volume":"35","author":"Liu","year":"2012","unstructured":"Liu, Y., & Zeng, G. Cancer and Innate Immune System Interactions: Translational Potentials for Cancer Immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 35 (4), 299-308 (2012).","journal-title":"Journal of Immunotherapy"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40425-017-0283-9","type":"journal-article","article-title":"The immune system in cancer metastasis: friend or foe","volume":"5","author":"Janssen","year":"2017","unstructured":"Janssen, L. M. E., Ramsay, E. E., Logsdon, C. D., & Overwijk, W. W. The immune system in cancer metastasis: friend or foe? Journal for ImmunoTherapy of Cancer. 5 (1), 79 (2017).","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2016\/4273943","type":"journal-article","article-title":"The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches","volume":"2016","author":"Pandya","year":"2016","unstructured":"Pandya, P. H., Murray, M. E., Pollok, K. E., & Renbarger, J. L. The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches. Journal of Immunology Research. 2016, 13 (2016).","journal-title":"Journal of Immunology Research"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","type":"journal-article","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","unstructured":"Vinay, D. S. et al. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Seminars in Cancer Biology. 35, S185-S198 (2015).","journal-title":"Seminars in Cancer Biology"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.cji.0000199193.29048.56","type":"journal-article","article-title":"Immune Suppression in the Tumor Microenvironment","volume":"29","author":"Gajewski","year":"2006","unstructured":"Gajewski, T. F., Meng, Y., & Harlin, H. Immune Suppression in the Tumor Microenvironment. Journal of Immunotherapy. 29 (3), 233-240 (2006).","journal-title":"Journal of Immunotherapy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","type":"journal-article","article-title":"Immune suppressive mechanisms in the tumor microenvironment","volume":"39","author":"Munn","year":"2016","unstructured":"Munn, D. H., & Bronte, V. Immune suppressive mechanisms in the tumor microenvironment. Current opinion in immunology. 39, 1-6 (2016).","journal-title":"Current opinion in immunology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","type":"journal-article","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","unstructured":"Vanderlugt, C. L., & Miller, S. D. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nature Reviews Immunology. 2, 85 (2002).","journal-title":"Nature Reviews Immunology"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2217\/imt.11.62","type":"journal-article","article-title":"Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients","volume":"3","author":"Hardwick","year":"2011","unstructured":"Hardwick, N., & Chain, B. Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients. Immunotherapy. 3 (6), 731-733 (2011).","journal-title":"Immunotherapy"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/0008-5472.CAN-14-2538","type":"journal-article","article-title":"Cancer Immunotherapy and Breaking Immune Tolerance-New Approaches to an Old Challenge","volume":"75","author":"Makkouk","year":"2015","unstructured":"Makkouk, A., & Weiner, G. Cancer Immunotherapy and Breaking Immune Tolerance-New Approaches to an Old Challenge. Cancer research. 75 (1), 5-10 (2015).","journal-title":"Cancer research"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/imt.14.51","type":"journal-article","article-title":"Targeting CD8(+) T-cell tolerance for cancer immunotherapy","volume":"6","author":"Jackson","year":"2014","unstructured":"Jackson, S. R., Yuan, J., & Teague, R. M. Targeting CD8(+) T-cell tolerance for cancer immunotherapy. Immunotherapy. 6 (7), 833-852 (2014).","journal-title":"Immunotherapy"},{"issue":"15_suppl","key":"ref13","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/jco.2011.29.15_suppl.2534","type":"journal-article","article-title":"Lymphodepletion and tumor burden govern clinical responses in patients with B-cell malignancies treated with autologous, CD19-targeted T cells","volume":"29","author":"Brentjens","year":"2011","unstructured":"Brentjens, R. J. et al. Lymphodepletion and tumor burden govern clinical responses in patients with B-cell malignancies treated with autologous, CD19-targeted T cells. Journal of Clinical Oncology. 29 (15_suppl), 2534-2534 (2011).","journal-title":"Journal of Clinical Oncology"},{"issue":"18","key":"ref14","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","type":"journal-article","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","unstructured":"Brentjens, R. J. et al. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood. 118 (18), 4817 (2011).","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","type":"journal-article","article-title":"Kinetics and Biomarkers of Severe Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-modified T Cell Therapy","volume":"130","author":"Hay","year":"2017","unstructured":"Hay, K. A. et al. Kinetics and Biomarkers of Severe Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-modified T Cell Therapy. Blood. 130, 2295-2306, (2017).","journal-title":"Blood"},{"issue":"32","key":"ref16","doi-asserted-by":"crossref","first-page":"33961","DOI":"10.18632\/oncotarget.5582","type":"journal-article","article-title":"Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis","volume":"6","author":"Zhang","year":"2015","unstructured":"Zhang, T. et al. Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis. Oncotarget. 6 (32), 33961-33971 (2015).","journal-title":"Oncotarget"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.omto.2017.12.003","type":"journal-article","article-title":"CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity","volume":"8","author":"Kueberuwa","year":"2018","unstructured":"Kueberuwa, G., Kalaitsidou, M., Cheadle, E., Hawkins, R. E., & Gilham, D. E. CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity. Molecular Therapy - Oncolytics. 8, 41-51 (2018).","journal-title":"Molecular Therapy - Oncolytics"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/104303403322167993","type":"journal-article","article-title":"Retroviral vectors for high-level transgene expression in T lymphocytes","volume":"14","author":"Engels","year":"2003","unstructured":"Engels, B. et al. Retroviral vectors for high-level transgene expression in T lymphocytes. Human Gene Therapy. 14 (12), 1155-1168 (2003).","journal-title":"Human Gene Therapy"},{"issue":"54","key":"ref19","first-page":"e2966","type":"journal-article","article-title":"Diagnostic Necropsy and Selected Tissue and Sample Collection in Rats and Mice","author":"Parkinson","year":"2011","unstructured":"Parkinson, C. M. et al. Diagnostic Necropsy and Selected Tissue and Sample Collection in Rats and Mice. Journal of Visualized Experiments : JoVE. (54), 2966 (2011).","journal-title":"Journal of Visualized Experiments: JoVE"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40425-017-0216-7","type":"journal-article","article-title":"CCR7(+) selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo","volume":"5","author":"Kueberuwa","year":"2017","unstructured":"Kueberuwa, G. et al. CCR7(+) selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo. Journal for Immunotherapy of Cancer. 5, 14 (2017).","journal-title":"Journal for Immunotherapy of Cancer"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/video\/58492\/a-syngeneic-mouse-b-cell-lymphoma-model-for-pre-clinical-evaluation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:16:14Z","timestamp":1792664174000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/58492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":20,"journal-issue":{"issue":"140","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3791\/58492","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]}}}